1,314
Views
12
CrossRef citations to date
0
Altmetric
Commentary

Breaking the cycle of opioid use disorder with Ibogaine

, PhD
Pages 1-3 | Published online: 07 Dec 2017
 

Declaration of interest and financial disclosures

The author is an inventor on issued patents pertaining to the active metabolite of ibogaine. She is a founder and shareholder in a Florida corporation, DemeRx, Inc., which is advancing clinical trials of noribogaine for opioid detoxification and maintenance therapy, among other indications. The author conducted offshore ibogaine research studies with government approval in St. Kitts, West Indies.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 987.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.